Porpaczy E, Tripolt S, Hoelbl-Kovacic A, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy. Blood. 2018;132(7):694-706.

Zdroj: In Blood 14 February 2019 133(7):768-768
Databáze: ScienceDirect
Externí odkaz: